Allergy and Immunology · Tarentum, PA
NPI
1720198393
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
301 E 5th Ave
Tarentum, PA, 15084
Phone (724) 224-5440
Groups this clinician bills Medicare through
Medicare paid, 2024
$126K
13,861 services
Medicare patients, 2024
271
Average age 71
Drug cost, 2024
$639K
3,142 prescriptions
Company payments, 2025
$12K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kumar R Patel was code 95165 (treatment - miscellaneous), 7,510 times for 181 patients. In total Kumar R Patel billed 13,861 services in 21 codes, and Medicare paid $126K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 7,510 | 181 | $9.21 | $69K |
| 95117 Treatment - Miscellaneous | Office | 3,201 | 193 | $7.38 | $24K |
| 95004 Test - Miscellaneous | Office | 2,059 | 43 | $2.40 | $4,944 |
| 95024 Test - Miscellaneous | Office | 509 | 43 | $5.26 | $2,676 |
| 99213 Office E&M - Established | Office | 284 | 175 | $56.65 | $16K |
| 94010 Pulmonary Function Testing | Office | 37 | 35 | $16.79 | $621 |
| 99214 Office E&M - Established | Office | 28 | 22 | $78.99 | $2,212 |
| 99203 Office E&M - New | Office | 27 | 26 | $64.05 | $1,729 |
| 99204 Office E&M - New | Office | 19 | 19 | $110.96 | $2,108 |
| 94060 Pulmonary Function Testing | Office | 17 | 17 | $22.04 | $375 |
By year: 2022 $164K for 14,759 services; 2023 $153K for 14,445 services; 2024 $126K for 13,861 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kumar R Patel prescribed most often to Medicare patients was Montelukast Sodium, with 529 prescriptions and refills. In total Kumar R Patel wrote 3,142 Medicare prescriptions that cost $639K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 529 | 832 | 116 | $4,879 |
| Fluticasone Propionate Generic | 458 | 570 | 172 | $4,870 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 335 | 407 | 156 | $10K |
| Azelastine Hcl Generic | 300 | 439 | 125 | $8,017 |
| Levocetirizine Dihydrochloride Generic | 230 | 300 | 43 | $2,603 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 186 | 220 | 42 | $139K |
| Famotidine Generic | 118 | 176 | 35 | $657 |
| Epinephrine Generic | 111 | 123 | 98 | $30K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 88 | 138 | 30 | $18K |
| Breo Ellipta Fluticasone/Vilanterol | 83 | 95 | 17 | $35K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 76 | 86 | 27 | $15K |
| Arnuity Ellipta Fluticasone Furoate | 64 | 88 | 15 | $18K |
| Ventolin Hfa Albuterol Sulfate | 45 | 51 | 20 | $2,709 |
| Hydroxyzine Hcl Generic | 40 | 54 | 11 | $391 |
| Symbicort Budesonide/Formoterol Fumarate | 35 | 43 | 11 | $9,156 |
Brand drugs: 975 claims; generic drugs: 2,167 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kumar R Patel $12K ($12K in general payments such as food, travel and fees) from 18 companies. The largest payer was Novartis Pharmaceuticals Corporation with $6,949.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 31 | $6,949 |
| AstraZeneca Pharmaceuticals LP AZN | 37 | $1,135 |
| GlaxoSmithKline, LLC. GSK | 36 | $763 |
| Genzyme Corporation SNY | 15 | $578 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 26 | $566 |
| Regeneron Healthcare Solutions, Inc. REGN | 19 | $347 |
| Amgen Inc. AMGN | 19 | $332 |
| CSL Behring CSL.AX | 17 | $313 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $199 |
| Genentech USA, Inc. ROG.SW | 3 | $86.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.